133 related articles for article (PubMed ID: 25168841)
21. Advisory opinion of the AWMF Ad hoc Commission In-vitro Diagnostic Medical Devices regarding in-vitro diagnostic medical devices manufactured and used only within health institutions established in the Union according to Regulation (EU) 2017/746 (IVDR).
Hoffmüller P; Brüggemann M; Eggermann T; Ghoreschi K; Haase D; Hofmann J; Hunfeld KP; Koch K; Meisel C; Michl P; Müller J; Müller C; Rabenau HF; Reinhardt D; Riemenschneider MJ; Sachs UJ; Sack U; Stenzinger A; Streichert T; von Neuhoff N; Weichert W; Weinstock C; Zimmermann S; Spitzenberger F;
Ger Med Sci; 2021; 19():Doc08. PubMed ID: 34194291
[TBL] [Abstract][Full Text] [Related]
22. European medical device regulation: a new era?
Donawa M
Med Device Technol; 2004 Dec; 15(10):30-1. PubMed ID: 16225282
[TBL] [Abstract][Full Text] [Related]
23. [Official experimental testing of biomedical products. Regulatory frame and importance of for quality, safety and efficacy].
Vieths S; Seitz R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1133-8. PubMed ID: 25123139
[TBL] [Abstract][Full Text] [Related]
24. The marketing of health products, with special reference to do-it-yourself tests.
Gevers S
Med Law; 2003; 22(2):199-206. PubMed ID: 12889639
[TBL] [Abstract][Full Text] [Related]
25. [Testing of vaccines. The challenge of testing complex combination vaccines].
Merkle A; Lechner H; Oppling V; Meyer H
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1188-92. PubMed ID: 25204275
[TBL] [Abstract][Full Text] [Related]
26. The new IVD Regulation 2017/746: a case study at a large university hospital laboratory in Belgium demonstrates the need for clarification on the degrees of freedom laboratories have to use lab-developed tests to improve patient care.
Vermeersch P; Van Aelst T; Dequeker EMC
Clin Chem Lab Med; 2020 Jul; 59(1):101-106. PubMed ID: 32692695
[TBL] [Abstract][Full Text] [Related]
27. The IVD directive: late-phase practicalities.
Johnson P; Walker R
Med Device Technol; 2003 Nov; 14(9):35-6. PubMed ID: 14682022
[No Abstract] [Full Text] [Related]
28. [Testing of medicinal products produced from pooled plasma].
Unkelbach U; Hunfeld A; Breitner-Ruddock S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1181-4. PubMed ID: 25213735
[TBL] [Abstract][Full Text] [Related]
29. Has the introduction of the European Parliament Directive 98/79/EC from 1998-10-27--concerning in-vitro diagnostic devices (IVD-directive) influenced performance of hormone immunoassay kits in terms of precision and accuracy? Results from selected external quality assessment (EQA) schemes between 1993 and 2008.
Wood WG
Clin Lab; 2009; 55(3-4):86-105. PubMed ID: 19462931
[TBL] [Abstract][Full Text] [Related]
30. In vitro diagnostics for screening the blood supply: the new European regulation for IVD and the WHO IVD prequalification programme.
Mbunkah HA; Reinhardt J; Kafere C; Scheiblauer H; Prat I; Nübling CM
Vox Sang; 2021 Jan; 116(1):3-12. PubMed ID: 32986873
[TBL] [Abstract][Full Text] [Related]
31. [Procedures and methods of benefit assessments for medicines in Germany].
Bekkering GE; Kleijnen J
Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
[TBL] [Abstract][Full Text] [Related]
32. Clinical evaluations clinical investigations under the amended Medical Device Directive.
Dannhorn DR; Schwabedissen H
Med Device Technol; 2008 Sep; 19(5):16-8, 20. PubMed ID: 18947145
[TBL] [Abstract][Full Text] [Related]
33. [Experimental testing of centrally authorised medicinal products. The CAP programme].
Giess S
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Oct; 57(10):1169-72. PubMed ID: 25159224
[TBL] [Abstract][Full Text] [Related]
34. Coping with the IVD directive.
Gower G
Med Device Technol; 2000 Oct; 11(8):28-9. PubMed ID: 11185185
[TBL] [Abstract][Full Text] [Related]
35. Choosing an IVD notified body: start now and gain a competitive edge.
Suppo M
Med Device Technol; 1998; 9(6):28-30. PubMed ID: 10182123
[TBL] [Abstract][Full Text] [Related]
36. [Medical devices. Regulatory framework and contribution of the German Federal Institute for Drugs and Medical Devices (BfArM) to the safe application].
Lauer W; Stößlein E; Brinker A; Broich K
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Dec; 57(12):1355-61. PubMed ID: 25370170
[TBL] [Abstract][Full Text] [Related]
37. Field safety notices released by manufacturers in cases of failure of products for infection testing: analysis of cases reported to the BfArM between 2005 and 2007.
Siekmeier R; Lisson K; Wetzel D
Eur J Med Res; 2010 Nov; 15 Suppl 2(Suppl 2):175-83. PubMed ID: 21147647
[TBL] [Abstract][Full Text] [Related]
38. [In vitro diagnostic medical devices--the legal context].
Látal T
Klin Mikrobiol Infekc Lek; 2009 Dec; 15(6):196-200. PubMed ID: 20077396
[TBL] [Abstract][Full Text] [Related]
39. [Focus Notified Bodies. New requirements for designation and monitoring].
Poos U; Edelhäuser R
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Dec; 57(12):1362-7. PubMed ID: 25373553
[TBL] [Abstract][Full Text] [Related]
40. Similarities and differences in the oncology drug approval process between FDA and European Union with emphasis on in vitro companion diagnostics.
Senderowicz AM; Pfaff O
Clin Cancer Res; 2014 Mar; 20(6):1445-52. PubMed ID: 24634467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
